Kaos Capital Ltd

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Psyence Biomedical Ltd. 13D/A Amendment 1 PBM · 74449F308	PBM	74449F308	4.9%	313,876	13D/A Amendment 1	1/13/2026 Event 1/8/2026
KAOS Capital Ltd.			4.9%	313,876
Adam Arviv			4.9%	313,876
Psyence Biomedical Ltd. 13D PBM · 74449F308	PBM	74449F308	16.8%	313,876	13D	12/10/2025 Event 11/25/2025
KAOS Capital Ltd.			16.8%	313,876
Adam Arviv			16.8%	313,876

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.